Supernus, Inc. Common Stock SUPN
i
Market dataready · fetched 2026-11-13T02:53:45.867Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T00:16:51.445477052Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-13T02:53:45.210431+00:00
Supernus, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | 37.90 | 251.7% | 35.7% | 27.09 | 121.3% | 11.1% |
| 35Δ | 34.25 | 203.9% | 23.3% | 27.62 | 141.6% | 11.1% |
| 40Δ | 32.12 | 169.1% | 16.2% | |||
| 45Δ | ||||||
| 50Δ | ||||||
| 55Δ | ||||||
| 60Δ | 28.46 | 103.7% | 4.9% | |||
| 65Δ | 27.92 | 98.1% | 3.8% | |||
| 70Δ | 30.93 | 67.7% | 1.8% | |||
| 75Δ | 26.43 | 116.5% | 3.0% | 31.17 | 62.0% | 1.4% |
| 80Δ | 25.92 | 106.3% | 2.0% | 31.42 | 56.4% | 1.0% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 37.90
- IV
- 251.7%
- B/E move
- 35.7%
- Pseudo strike
- 27.09
- IV
- 121.3%
- B/E move
- 11.1%
35Δ
- Pseudo strike
- 34.25
- IV
- 203.9%
- B/E move
- 23.3%
- Pseudo strike
- 27.62
- IV
- 141.6%
- B/E move
- 11.1%
40Δ
- Pseudo strike
- 32.12
- IV
- 169.1%
- B/E move
- 16.2%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 28.46
- IV
- 103.7%
- B/E move
- 4.9%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 27.92
- IV
- 98.1%
- B/E move
- 3.8%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 30.93
- IV
- 67.7%
- B/E move
- 1.8%
75Δ
- Pseudo strike
- 26.43
- IV
- 116.5%
- B/E move
- 3.0%
- Pseudo strike
- 31.17
- IV
- 62.0%
- B/E move
- 1.4%
80Δ
- Pseudo strike
- 25.92
- IV
- 106.3%
- B/E move
- 2.0%
- Pseudo strike
- 31.42
- IV
- 56.4%
- B/E move
- 1.0%
Options history
Table
| Date | IV (%) |
|---|---|
| 51.60% | |
| 50.53% | |
| 51.71% | |
| 51.41% | |
| 51.88% | |
| 53.71% | |
| 53.98% | |
| 53.81% | |
| 51.06% | |
| 42.80% |
Drug Manufacturers - Specialty & Generic
TAK
Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer…
More →TEVA
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North…
More →TKNO
Alpha Teknova Inc (TKNO) is a leading entity in the synthetic biology industry, specializing in the development of essential biological reagents and supplements that facilitate…
More →TLPH
Talphera Inc. is a pioneering biotechnology company dedicated to advancing peptide-based therapies for rare diseases and significant unmet medical needs. Its promising pipeline,…
More →TLRY
Description unavailable
More →TRLV
Description unavailable
More →